Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,368	8,005	4,035	5,146	2,341	3,366
Market Cap Growth	-52.49%	98.37%	-21.58%	119.79%	-30.45%	-39.05%
Enterprise Value	7,205	7,926	4,078	5,109	2,260	3,101
Last Close Price	17.63	19.24	9.76	12.55	5.71	8.21

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	117.29	169.28	2694.18	-	-	-
Forward PE	97.94	178.98	81.33	70.82	70.82	64.39
PS Ratio	13.06	15.24	8.80	14.99	12.14	17.32
PB Ratio	6.92	8.34	4.49	5.97	2.64	3.56
P/TBV Ratio	9.41	11.26	6.39	6.71	2.95	3.94
P/FCF Ratio	51.36	68.96	65.91	-	-	-
P/OCF Ratio	40.15	49.45	30.75	90.53	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	12.77	15.09	8.89	14.89	11.72	15.95
EV/EBITDA Ratio	45.10	66.84	131.72	-	-	-
EV/EBIT Ratio	83.39	143.76	-	-	-	-
EV/FCF Ratio	50.22	68.29	66.61	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.13	0.22	0.25	0.23	0.07	0.05
Debt / EBITDA Ratio	0.88	1.64	5.21	-	-	-
Debt / FCF Ratio	0.98	1.82	3.68	-	-	-
Net Debt / Equity Ratio	-0.22	-0.19	-0.07	0.01	-0.16	-0.26
Net Debt / EBITDA Ratio	-1.58	-1.56	-2.15	-0.45	0.84	2.14
Net Debt / FCF Ratio	-1.64	-1.59	-1.09	-1.00	0.65	1.11
Asset Turnover	0.43	0.40	0.37	0.31	0.18	0.17
Inventory Turnover	1.94	2.03	1.86	1.35	0.94	0.81
Quick Ratio	2.03	1.26	1.62	1.31	1.70	3.25
Current Ratio	2.54	1.56	2.10	2.28	2.69	4.65
Return on Equity (ROE)	7.31%	5.11%	-0.44%	-4.96%	-18.91%	-12.98%
Return on Assets (ROA)	4.13%	2.60%	-1.76%	-4.16%	-12.81%	-8.95%
Return on Invested Capital (ROIC)	8.19%	4.76%	-4.11%	-9.29%	-30.81%	-26.91%
Return on Capital Employed (ROCE)	7.70%	5.40%	-3.20%	-7.20%	-23.80%	-16.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	0.93%	0.59%	0.04%	-0.77%	-6.94%	-3.89%
FCF Yield	1.95%	1.45%	1.52%	-0.21%	-9.49%	-6.49%
Payout Ratio	5.79%	8.87%	274.39%	-	-	-
Buyback Yield / Dilution	-32.97%	-14.80%	5.51%	2.38%	0.66%	0.33%
Total Shareholder Return	-32.97%	-14.80%	5.51%	2.38%	0.66%	0.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error